|
Early bird ends Sept. 8. A fireside chat with Donald Ingber and how the 11 get picked No images? Click here 
Hundreds of private biotechs scrutinized, argued over, cut.A summer of debate over which biotechs are truly innovative, and which fall short, comes down to eleven names. We'll reveal them live in Boston on Sept. 24 to a room full of the winning founders, scientists and investors. "It's a little weird, it's interesting, it's a place a lot of other people have struggled." "When they have data, we'll write a big story about it. But they're not landing on the E11 list this year." This year we're also sitting down with Donald Ingber, founding director of the Wyss Institute and a pioneer of Organ Chip technology, on the state of discovery and where this list fits. Save $100 with the early bird rate. Ends Sept. 8 at 11:59 pm ET. 
It's an intentionally intimate evening, built for real conversation rather than a panel and a name badge. Come for the reveal. Stay for the people you'll be glad you met. Save $100 with the early bird rate. Ends Sept. 8 at 11:59 pm ET. SPONSORED BY 
COMMUNITY PARTNER 
|
